RECOVER: Sleep
RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
- Sex at Birth: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase I/II
- Conditions Being Studied: COVID-19
Study Purpose
The purpose of this research study is to find out if certain study interventions can help treat sleep disturbances that started or got worse following a COVID infection and have lasted for at least 12 weeks. Sleep disturbances include excessive drowsiness, problems falling and staying asleep, and problems with sleep-wake patterns. The amount of time you are expected to participate in the research study will depend on which sub-study you are assigned. Participation in the current sub-studies may last between 13 and 18 weeks. This includes an end of study phone call about 4 weeks after the end of the study intervention.
Who Can Participate
Age: 18 and older
Locations
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: SITE00002117
- StudyID: 2023-01325
- ClinicalTrials.gov: N/A
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422